These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9451904)

  • 1. [Effect of combined captopril-spironolactone therapy of cardiac insufficiency on kidney function and serum electrolyte values].
    Cserhalmi L
    Orv Hetil; 1998 Jan; 139(2):63-6. PubMed ID: 9451904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined effects of low-dose spironolactone and captopril therapy in a rat model of genetic hypertrophic cardiomyopathy.
    de Resende MM; Kriegel AJ; Greene AS
    J Cardiovasc Pharmacol; 2006 Dec; 48(6):265-73. PubMed ID: 17204904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
    J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kalemia during combined therapy with an angiotensin converting enzyme inhibitor and a potassium-sparing diuretic.
    Mooser V; Waeber G; Bidiville J; Waeber B; Nussberger J; Brunner HR
    J Clin Hypertens; 1987 Dec; 3(4):510-3. PubMed ID: 2839627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Captopril and spironolactone therapy for refractory congestive heart failure.
    Dahlström U; Karlsson E
    Am J Cardiol; 1993 Jan; 71(3):29A-33A. PubMed ID: 8422001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of combined therapy with captopril, furosemide, and a sodium-restricted diet on serum electrolyte concentrations and renal function in normal dogs and dogs with congestive heart failure.
    Roudebush P; Allen TA; Kuehn NF; Magerkurth JH; Bowers TL
    J Vet Intern Med; 1994; 8(5):337-42. PubMed ID: 7837109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined therapy of captopril and spironolactone for refractory congestive heart failure.
    Han YL; Tong M; Jing QM; Hu XL; Liu JQ
    Chin Med J (Engl); 1994 Sep; 107(9):688-92. PubMed ID: 7805462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dangerous hyperkalemia as sequelae of new treatment strategies of heart failure].
    Fuster D; Frey FJ; Ferrari P
    Praxis (Bern 1994); 2000 Dec; 89(49):2073-6. PubMed ID: 11190849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metabolic and acid-base changes in intensive diuretic therapy in heart failure].
    Krátký V; Bartonová J; Hrdina R
    Vnitr Lek; 1990 Apr; 36(4):330-41. PubMed ID: 2192496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure.
    Shah KB; Rao K; Sawyer R; Gottlieb SS
    J Am Coll Cardiol; 2005 Sep; 46(5):845-9. PubMed ID: 16139135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long term therapy over nine years with Spironolacton in hydropic cardiac insufficiency].
    Ehrlich U; Klepzig H
    Med Klin; 1976 Sep; 71(38):1546-54. PubMed ID: 135920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure.
    Tamirisa KP; Aaronson KD; Koelling TM
    Am Heart J; 2004 Dec; 148(6):971-8. PubMed ID: 15632880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adaptation of guidelines for the treatment of chronic heart failure in a specialized heart failure clinic].
    Pölzl G; Gouya G; Hügel H; Frick M; Ulmer H; Pachinger O
    Wien Klin Wochenschr; 2002 Oct; 114(19-20):833-9. PubMed ID: 12503474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fixed-dose combination of furosemide and spironolactone in digitalized congestive heart failure patients.
    Yasky J; Ledesma GA; Tutera A; Collia LF
    Pharmatherapeutica; 1986; 4(8):473-9. PubMed ID: 3714755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined angiotensin-converting enzyme inhibition and adrenomedullin in an ovine model of heart failure.
    Rademaker MT; Charles CJ; Cooper GJ; Coy DH; Espiner EA; Lewis LK; Nicholls MG; Richards AM
    Clin Sci (Lond); 2002 Jun; 102(6):653-60. PubMed ID: 12049620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of non-digitalized congestive heart failure patients with a fixed-dose combination of furosemide and spironolactone.
    Yasky J; Ledesma GA; Tutera A; Collia LF
    Pharmatherapeutica; 1986; 4(8):480-5. PubMed ID: 3714756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spironolactone in severe heart failure: enhances efficacy of diuretic + ACE inhibitor combinations.
    Prescrire Int; 2000 Oct; 9(49):158-9. PubMed ID: 11603418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Severe complications during enalapril therapy for heart insufficiency].
    Wieland T; Stäubli M
    Schweiz Med Wochenschr; 1988 Dec; 118(48):1789-92. PubMed ID: 2849806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.